NineSigma Innovation Alliance Program Surpasses 1 Million Members
June 17, 2008 10:29 ET
|
NineSigma, Inc.
CLEVELAND, OH--(Marketwire - June 17, 2008) - NineSigma, the leading provider of open innovation
solutions, today announced that its Innovation Alliance Program has
surpassed more than 1 million...
NineSigma Partners With International Science and Technology Center
June 10, 2008 10:08 ET
|
NineSigma, Inc.
CLEVELAND, OH--(Marketwire - June 10, 2008) - NineSigma, the leading provider of open innovation (OI)
solutions, today announced that Moscow-based International Science and
Technology Center (ISTC)...
Effective Drug Development Metrics Link Operations With Strategy, According to Tufts Center for the Study of Drug Development
June 10, 2008 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - June 10, 2008) - Research-based drug companies looking to
streamline the development of new medicinal products should adopt metrics
that link their R&D activities with...
NineSigma RFS Open Innovation Service Connects Innovation Seekers With "Known" Solutions
May 28, 2008 12:54 ET
|
NineSigma, Inc.
CLEVELAND, OH--(Marketwire - May 28, 2008) - NineSigma, the leading provider of
open innovation (OI) solutions, today introduced its new Request for
Solution (RFS) service, which quickly connects...
NineSigma Closes $4 Million Equity Round
May 06, 2008 10:02 ET
|
NineSigma, Inc.
CLEVELAND, OH--(Marketwire - May 6, 2008) - NineSigma, the leading provider of open innovation
solutions to Global 1000 companies, today announced that it has closed a $4
million financing round. The...
Medicare Prescription Drug Plans Not Fully Compliant With Federal Regulations, According to Tufts Center for the Study of Drug Development
May 06, 2008 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - May 6, 2008) - A new study by the Tufts Center for the Study of
Drug Development has found that Medicare prescription drug plans that came
into being following the landmark...
NineSigma Taps Denys Resnick to Lead New Open Innovation Services Team
April 15, 2008 09:47 ET
|
NineSigma, Inc.
CLEVELAND, OH--(Marketwire - April 15, 2008) - NineSigma, the leading provider of
open innovation (OI) solutions, today announced the appointment of Denys
Resnick as engagement manager. Resnick will...
NineSigma Expands European Presence With New Headquarters
April 09, 2008 11:26 ET
|
NineSigma, Inc.
CLEVELAND, OH--(Marketwire - April 9, 2008) - NineSigma, the leading provider of
open innovation (OI) solutions, today announced the expansion of its
European activities with the opening of its new...
Effective Drug Development Outsourcing Requires a Plan, According to Tufts Center for the Study of Drug Development
April 02, 2008 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - April 2, 2008) - While the trend to outsource key elements of
drug development to service providers could slow down due in part to rising
operating costs worldwide, drug...
Number of Monoclonal Antibody Products in Development Nearly Tripled in Last Decade, According to Tufts Center for the Study of Drug Development
March 11, 2008 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - March 11, 2008) - The number of monoclonal antibody products --
known as mAbs -- entering clinical study nearly tripled in the last decade
and now require 7.6 years on...